TRABID overexpression in prostate cancer patient samples and TRABID overexpression-mediated HR activity inhibition and chromosomal instability prompted us to determine whether overexpressed TRABID enables synthetic lethality to PARP inhibitor in prostate cancer cells. The gene discussed is ZRANB1; the disease is Familial prostate cancer.